![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and ... Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Show more
SolarEdge Technologies (NASDAQ:SEDG) – SolarEdge Technologies faces a 13.1% drop in pre-market trading after announcing the issuance of $300 million in senior convertible notes due 2029 and...
Illumina completes the divestiture of GRAIL PR Newswire SAN DIEGO, June 24, 2024 GRAIL spin-off complete; GRAIL to begin regular way trading as "GRAL" on June 25Illumina to issue second quarter...
Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations PR Newswire SAN DIEGO, June 11, 2024 Latest version includes a prebuilt pangenome capturing more...
Apple (NASDAQ:AAPL) – At today’s Apple Developer Conference (WWDC 2024) kicking off today, the company will demonstrate its prowess in the advanced field of artificial intelligence...
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK, June 7, 2024 NEW YORK, June 7, 2024 /PRNewswire/...
Intel (NASDAQ:INTC), Apollo Global Management (NYSE:APO) – Intel launched its sixth-generation Xeon processors for servers and Gaudi 3 AI accelerators at competitive prices, aiming to...
Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost PR Newswire SAN DIEGO, June 4, 2024 SAN...
Period β | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.23 | -0.212943245996 | 108.01 | 112.485 | 106.09 | 11129177 | 108.75203287 | CS |
4 | 3.81 | 3.66451861114 | 103.97 | 119 | 100.085 | 4637484 | 108.5612939 | CS |
12 | -19.42 | -15.2672955975 | 127.2 | 135.26 | 100.085 | 2590740 | 112.53465763 | CS |
26 | -32.91 | -23.3918544317 | 140.69 | 148.19 | 100.085 | 2136281 | 123.49606734 | CS |
52 | -93.39 | -46.4234229756 | 201.17 | 201.17 | 89 | 2112821 | 129.43993766 | CS |
156 | -371.49 | -77.5116322741 | 479.27 | 526 | 89 | 1499896 | 201.44802922 | CS |
260 | -250.37 | -69.9064637722 | 358.15 | 555.77 | 89 | 1348125 | 246.14349749 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions